Suven Pharmaceuticals Limited Capital Reinvestment Ratio
Suven Pharmaceuticals Limited capital reinvestment ratio. Suven Pharmaceuticals Limited (SUVENPHAR) has a Capital Reinvestment Ratio of 0.24x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.04 Billion) in capital expenditures (Rs248.54 Million). Check SUVENPHAR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Suven Pharmaceuticals Limited (2019–2025)
Capital reinvestment ratio of Suven Pharmaceuticals Limited from 2019 to 2025. This chart tracks Suven Pharmaceuticals Limited's Capital Reinvestment Ratio across 7 annual periods. Also explore SUVENPHAR net assets growth trend to track the company's year-over-year net asset growth rate.
Suven Pharmaceuticals Limited Capital Reinvestment Ratio by Year (2019–2025)
Suven Pharmaceuticals Limited capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited (SUVENPHAR) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | Rs2.88 Billion | Rs1.56 Billion | ▲ +274.1% |
| 2024 | 0.14x | Rs3.58 Billion | Rs517.87 Million | ▼ -77.2% |
| 2023 | 0.63x | Rs4.51 Billion | Rs2.86 Billion | ▲ +178.2% |
| 2022 | 0.23x | Rs3.30 Billion | Rs751.87 Million | ▼ -21.2% |
| 2021 | 0.29x | Rs3.83 Billion | Rs1.11 Billion | ▲ +21.0% |
| 2020 | 0.24x | Rs4.16 Billion | Rs994.15 Million | ▼ -78.8% |
| 2019 | 1.13x | Rs504.05 Million | Rs567.86 Million | — |